OBJECTIVES: To examine human leukocyte antigen HLA DRB1-DQB1 haplotypes within a multi-ethnic cohort and assess their association with characteristics of diabetes onset. METHODS: The sample included 1662 participants from the SEARCH for Diabetes in Youth Study who tested positive for GADA and/or IA-2A autoantibodies. Blood drawn at the study visit was used to measure fasting C-peptide (FCP) and genotype HLA DRB1 and DQB1 loci. Diabetic ketoacidosis (DKA) at diagnosis was determined from medical records. Multivariable linear and logistic regression models stratified by race/ethnicity were used to assess associations with DRB1-DQB1 haplotypes. RESULTS: The frequency of DRB1*03 susceptibility haplotypes ranged 27.5-28.9% in all racial/ethnic groups. The frequency of susceptibility DRB1*04-DQB1*0302 was higher in non-Hispanic White (NHW; 34.1%) and Hispanic (38.9%) compared to non-Hispanic Black (NHB; 20.8%) youth. Neutral and protective haplotypes were low frequency in all groups. DBR1*03 haplotypes were associated with younger age at diagnosis in NHW and positivity for multiple autoantibodies in Hispanics. DRB1*04-DQB1*0302 haplotypes were associated with multiple autoantibody positivity in NHW and Hispanics, and lower FCP and higher odds of DKA in Hispanics only. Although protective DRB1*04-DQB1*0301 haplotypes were associated with older age at diagnosis in NHW, they were also associated with multiple autoantibody positivity in these youth. Protective DRB1*13 haplotypes were associated with decreased odds of multiple autoantibody positivity in NHB youth. CONCLUSIONS: The distribution of DRB1-DQB1 haplotypes and their association with onset-related characteristics of autoimmune diabetes varies across major racial/ethnic groups in the USA. This may contribute to variation in clinical presentation of autoimmune diabetes by race/ethnicity.
OBJECTIVES: To examine humanleukocyte antigen HLA DRB1-DQB1 haplotypes within a multi-ethnic cohort and assess their association with characteristics of diabetes onset. METHODS: The sample included 1662 participants from the SEARCH for Diabetes in Youth Study who tested positive for GADA and/or IA-2A autoantibodies. Blood drawn at the study visit was used to measure fasting C-peptide (FCP) and genotype HLA DRB1 and DQB1 loci. Diabetic ketoacidosis (DKA) at diagnosis was determined from medical records. Multivariable linear and logistic regression models stratified by race/ethnicity were used to assess associations with DRB1-DQB1 haplotypes. RESULTS: The frequency of DRB1*03 susceptibility haplotypes ranged 27.5-28.9% in all racial/ethnic groups. The frequency of susceptibility DRB1*04-DQB1*0302 was higher in non-Hispanic White (NHW; 34.1%) and Hispanic (38.9%) compared to non-Hispanic Black (NHB; 20.8%) youth. Neutral and protective haplotypes were low frequency in all groups. DBR1*03 haplotypes were associated with younger age at diagnosis in NHW and positivity for multiple autoantibodies in Hispanics. DRB1*04-DQB1*0302 haplotypes were associated with multiple autoantibody positivity in NHW and Hispanics, and lower FCP and higher odds of DKA in Hispanics only. Although protective DRB1*04-DQB1*0301 haplotypes were associated with older age at diagnosis in NHW, they were also associated with multiple autoantibody positivity in these youth. Protective DRB1*13 haplotypes were associated with decreased odds of multiple autoantibody positivity in NHB youth. CONCLUSIONS: The distribution of DRB1-DQB1 haplotypes and their association with onset-related characteristics of autoimmune diabetes varies across major racial/ethnic groups in the USA. This may contribute to variation in clinical presentation of autoimmune diabetes by race/ethnicity.
Authors: C F Verge; R Gianani; E Kawasaki; L Yu; M Pietropaolo; R A Jackson; H P Chase; G S Eisenbarth Journal: Diabetes Date: 1996-07 Impact factor: 9.461
Authors: Deborah D Ingram; Jennifer D Parker; Nathaniel Schenker; James A Weed; Brady Hamilton; Elizabeth Arias; Jennifer H Madans Journal: Vital Health Stat 2 Date: 2003-09
Authors: A Paul Lambert; Kathleen M Gillespie; Glenys Thomson; Heather J Cordell; John A Todd; Edwin A M Gale; Polly J Bingley Journal: J Clin Endocrinol Metab Date: 2004-08 Impact factor: 5.958
Authors: H A Erlich; A Zeidler; J Chang; S Shaw; L J Raffel; W Klitz; Y Beshkov; G Costin; S Pressman; T Bugawan Journal: Nat Genet Date: 1993-04 Impact factor: 38.330
Authors: M M Zanone; E Catalfamo; S L Pietropaolo; I Rabbone; C Sacchetti; F Cerutti; M Trucco; P Cavallo-Perin Journal: Metabolism Date: 2003-01 Impact factor: 8.694
Authors: Mustafa Tosur; Susan M Geyer; Henry Rodriguez; Ingrid Libman; David A Baidal; Maria J Redondo Journal: Diabetologia Date: 2018-06-21 Impact factor: 10.122
Authors: Mustafa Tosur; Mario A Cleves; Jay M Sosenko; Ingrid Libman; David A Baidal; Ashok Balasubramanyam; Maria J Redondo Journal: J Clin Endocrinol Metab Date: 2020-12-01 Impact factor: 5.958
Authors: Richard F Hamman; Ronny A Bell; Dana Dabelea; Ralph B D'Agostino; Lawrence Dolan; Giuseppina Imperatore; Jean M Lawrence; Barbara Linder; Santica M Marcovina; Elizabeth J Mayer-Davis; Catherine Pihoker; Beatriz L Rodriguez; Sharon Saydah Journal: Diabetes Care Date: 2014-12 Impact factor: 19.112
Authors: Christina Reinauer; Joachim Rosenbauer; Christina Bächle; Christian Herder; Michael Roden; Sian Ellard; Elisa De Franco; Beate Karges; Reinhard W Holl; Jürgen Enczmann; Thomas Meissner Journal: Genes (Basel) Date: 2017-05-19 Impact factor: 4.096
Authors: Vassiliki Bravis; Akaal Kaur; Helen C Walkey; Ian F Godsland; Shivani Misra; Polly J Bingley; Alistair J K Williams; David B Dunger; Colin M Dayan; Mark Peakman; Nick S Oliver; Desmond G Johnston Journal: BMJ Open Date: 2018-04-04 Impact factor: 2.692